Sunwin International Neutraceuticals to Aggressively Pursue Opportunities in Europe After the European Commission's Recent Regulatory Approval of Stevia
Europe represents a vast market and Sunwin intends to work aggressively to establish European distribution of our Stevia products and work with industry leaders to develop unique products to address the needs of today's consumer seeking healthy, all natural, low calorie sweeteners."
November 28, 2011
Sunwin International Neutraceuticals, Inc. (OTC.BB: SUWN.OB - News), one of the top global providers of high quality Stevia extracts including Rebaudioside A 98, announced today that management intends to aggressively pursue opportunities in Europe after the European Commission's ("EC's")recent approval of Stevia for use in the food and beverage industry.
Share article on social media or email:
View article via: